- Oral presentation
- Open Access
A prospective randomized study of the natural history of idiopathic scoliosis versus treatment with the SpineCor brace
© Coillard et al; licensee BioMed Central Ltd. 2012
- Published: 27 January 2012
- Public Health
- High Risk
- Treated Group
- Family History
- Positive Outcome
The inclusion criteria where: 1) High risk of evolution: family history and/or proven progressive 2) No significant pathological malformation of the spine; 3) Girl or boy; 4) Initial Cobb angle between 15° and 30°; 5) Risser 0, 1 or 2. Assessment of brace effectiveness included; 1) percentage of patients who have 5° or less curve progression and the percentage of patients who have 6° or more progression at skeletal maturity, 2) percentage of patients who have had surgery recommendation/undergone before skeletal maturity.
At three years follow up a correction was achieved in 50% of treated patient and only in 9.5% of controls, stabilization in 23.1% treated and 33.4% in controls and progression in 26.9 % for the treated group and 59.1% for controls. Three immature patients required surgical fusion while receiving treatment (11.5%) as well as 3 control patients (14.3%). For the control patients we considered as a failure if the Cobb angle worsened by more then 5° from the original angle and the patient then received treatment.
The SpineCor brace is effective for the treatment of early adolescent idiopathic scoliosis comparing with its natural history. Moreover, the positive outcome appears to be maintained in the long term.
- Coillard C, Circo A, Rivard CH: A new concept for the non-invasive treatment of adolescent idiopathic scoliosis: the corrective movement principle integrated in the SpineCor system. Disabil Rehabil Assist Technol. 2008, 3 (3): 112-9. 10.1080/17483100801903913.View ArticlePubMedGoogle Scholar
- Coillard C, Circo AB, Rivard CH: SpineCor treatment for juvenile idiopathic scoliosis: SOSORT award 2010 winner. Scoliosis. 2010, 5: 25-10.1186/1748-7161-5-25.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.